Management of dyslipidemia for cardiovascular disease risk reduction: Synopsis of the 2014 U.S. department of veterans affairs and U.S. department of defense clinical practice guideline

John R. Downs, Patrick G. O'Malley

Research output: Contribution to journalArticlepeer-review

68 Scopus citations

Abstract

Description: In December 2014, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of dyslipidemia for cardiovascular disease risk reduction in adults. This synopsis summarizes the major recommendations. Methods: On 30 September 2013, the VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline development effort that included clinical stakeholders and conformed to the Institute of Medicine's tenets for trustworthy clinical practice guidelines. The guideline panel developed key questions, systematically searched and evaluated the literature, developed a simple 1-page algorithm, and rated each of 26 recommendations by using the Grading of Recommendations Assessment, Development, and Evaluation system. Recommendations: This synopsis summarizes key features of the guideline in 5 areas: elimination of treatment targets, additional tests for risk prediction, primary and secondary prevention, and laboratory testing.

Original languageEnglish (US)
Pages (from-to)291-297
Number of pages7
JournalAnnals of internal medicine
Volume163
Issue number4
DOIs
StatePublished - Aug 18 2015
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Management of dyslipidemia for cardiovascular disease risk reduction: Synopsis of the 2014 U.S. department of veterans affairs and U.S. department of defense clinical practice guideline'. Together they form a unique fingerprint.

Cite this